Business Segments Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 01:28:50 2025-02-12 pm EST 5-day change 1st Jan Change
12.83 USD +2.07% Intraday chart for Myriad Genetics, Inc. -0.62% -6.27%

Sales 2023 by Business Segment

See more © MarketScreener.com

Sales 2023 by Geography

See more © MarketScreener.com

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (USD)
Fiscal Period: December2014201520162017201820192020202120222023

Biological Products

          

Biotechnology

- - 691M 678M 753M

Total Assets

- - 1.32B 1.2B 1.15B

Interest Expense

- - -6.6M -3.2M -2.9M

Income Tax Expense

- - -29.9M -28.6M 1.1M

CAPEX

- - -18M -45.3M -63.2M

EBT

- - -57.1M -141M -262M

D&A

- - 62.8M 52.7M 61.9M

Operating Income

- - -190M -141M -257M

Net Income

- - -27.2M -112M -263M

Other

61.7M 56.2M - - -

Total Assets

155M 253M - - -

D&A

5.3M 4.6M - - -

Operating Income

-126M -173M - - -

Life Sciences Tools and Services

          

Companion Diagnostics

- - - - -

Total Assets

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Medical Testing, Analyzing, and Diagnostic Equipment

          

Diagnostics

789M 543M - - -

Total Assets

1.22B 994M - - -

D&A

67.7M 67M - - -

Operating Income

133M -2.8M - - -

Total Assets

192M 172M - - -

Gene Research and Development

          

Total Assets

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (USD)
Fiscal Period: December2014201520162017201820192020202120222023

United States

789M 551M 604M 592M 118M

Total Assets

1.27B 1.19B 871M 983M 962M

Rest of world

- 48.8M 86.9M 86.9M 1.3M

Total Assets

105M 56.8M 51.1M 45.6M 44M

Total Assets

192M - - - -

Total Assets

- 172M 399M 170M 141M